InvestorsHub Logo
Followers 199
Posts 17543
Boards Moderated 0
Alias Born 06/25/2014

Re: None

Monday, 02/08/2021 9:14:30 AM

Monday, February 08, 2021 9:14:30 AM

Post# of 194884
Full Year 2020 Performance Highlights

Consolidated gross sales across all locations for the twelve months ended December 31, 2020 totaled a Company record $40.6 million, representing year-over-year growth of 23% compared to the twelve months ended December 31, 2019.
Total prescriptions for the twelve months ended December 31, 2020 totaled 530,700, representing year-over-year growth of 16% compared to the twelve months ended December 31, 2019.
340B revenue was $2.8 million, representing year-over-year growth of 300% compared to the twelve months ended December 31, 2019.
Revenues from COVID-19 Rapid Testing totaled approximately $600,000 during 2020 with over 5000 tested.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RXMD News